Next Generation Sequencing Services Market Key Players Analysis of Agilent Technologies, Inc., Beijing Genomics Institute, GE Healthcare, Illumina Inc., Newgene Ltd., Novartis, OXFORD GENE TECHNOLOGY, OXFORD NANOPORE TECHNOLOGIES, Pacific Biosciences of C

Global Next Generation Sequencing market is valued approximately USD 3.5 billion. The market growth is majorly attributed to the factors such as growing applications of next generation sequencing and rising technological innovations in sequencing platforms. Further increasing demand for drug discovery and rising research spending are other prominent factors fuelling the growth in the market. However, data storage and analysis are still a major concern before handling the complex sequencing data.

Get Free Sample Copy of Report at https://www.researchformarkets.com/sample/global-next-generation-sequencing-services-market-11289

Some of the key market players are Life Sciences Corporation (Roche Holding), Agilent Technologies, Inc., Beijing Genomics Institute, GE Healthcare, Illumina Inc., Newgene Ltd., Novartis, OXFORD GENE TECHNOLOGY, OXFORD NANOPORE TECHNOLOGIES, Pacific Biosciences of California Inc., and Siemens. Acquisitions, mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.

Applications:
Diagnostics
Drug Discovery
Biomarker Discovery
Personalized Medicine
Agriculture and Animal Research
Other Applications

Technology:
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Sequencing by Ligation (SBL)
Pyrosequencing
Single-Molecule Real-Time Sequencing (SMRT)
Other Technologies

End User:
Research Centers and Academic & Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users

Browse Complete Report at https://www.researchformarkets.com/reports/global-next-generation-sequencing-services-market-11289

Table of Content

Chapter 1. Research Methodology

Chapter 2. Global Next Generation Sequencing Services Market Definition & scope

Chapter 3. Executive Summary

Chapter 4. Global Next Generation Sequencing Services Market Dynamics

Chapter 5. Global Next Generation Sequencing Market by Application

Chapter 6. Global Next Generation Sequencing Market by Technology

Chapter 7. Global Next Generation Sequencing Market by End User

Chapter 8. Global Next Generation Sequencing Market, Regional Analysis

Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Agilent Technologies
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Eurofins Scientific
9.3.3. F. Hoffmann-La Roche AG
9.3.4. GATC Biotech Ag
9.3.5. Illumina Incorporated
9.3.6. Macrogen, Inc.
9.3.7. Oxford Nanopore Technologies Ltd.
9.3.8. Pacific Biosciences of California, Inc.
9.3.9. Perkin Elmer, Inc.
9.3.10. Qiagen NV
9.3.11. Thermo Fischer Scientific Inc.

Place Direct Purchase Order of Next Generation Sequencing Services Market at https://www.researchformarkets.com/buy-now/global-next-generation-sequencing-services-market-11289/one

Scope of Report:
- Among various NGS technologies discussed in the report, the SBS technology accounted for the largest revenue share of the market in 2016. Development of advanced NGS platforms and the increasing demand for Illumina’s systems are the primary growth attributes for the development of SBS technology. Further, on the basis of applications, the market is dominated by diagnostic applications with highest revenue share in 2016. Companies are constantly focusing on the development of NGS based diagnostic tests. In July 2017, FDA has approved first NGS-based diagnostic test to Thermo Fisher Scientific. This is likely to spur the companies test procedures over the forecasts period.
- Geographically, the market is dominated by North America. The growth in the region is majorly driven by the rising number of collaboration among research institutions. Moreover, increasing focus of research institutes towards drug discovery is another key driving factor. Furthermore, Asia Pacific region is anticipated to grow with an eye popping CAGR over the forecasted period 2017-2025. The growth in the region is majorly driven by increasing and developing healthcare infrastructure in the region along with the rise in GPD contribution on healthcare sector.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Info:
Name: Research For Markets
Email: alan.naidu@researchformarkets.com
Phone: +44 8000-4182-37

Research For Markets indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East And Africa.

Level 21, Dashwood House
69 Old Broad Street
London EC2M 1QS, United Kingdom

This release was published on openPR.